Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies
This completed clinical trial update investigates bile duct colonization and postoperative infectious complications after pancreaticoduodene…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating intra-hepatic administration of TheraSphere in combination with intravenous chemotherapy for cholangioca…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Precise Treatment System of Biliary Malignancies Based on Special Disease Database
An ongoing clinical trial update describes a precision treatment system for biliary malignancies using a disease-specific database, sponsore…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma [Phase 2]
A Phase II trial of ceritinib (LDK378) for ROS1/ALK-overexpressed advanced intrahepatic or hilar cholangiocarcinoma has been terminated. The…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies [Phase 2]
A Phase 2 study evaluating ceritinib in ALK- and ROS1-activated gastrointestinal cancers has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: S-1 in Combination With Abraxane in Treating Cholangiocarcinoma [Phase 2]
Phase 2 trial update evaluating S-1 in combination with Abraxane for cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma [NA]
Completed clinical trial evaluating proton beam irradiation for unresectable hepatocellular carcinoma and cholangiocarcinoma, with results p…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection [Phase 2]
Phase 2 trial evaluating gemcitabine as adjuvant therapy after surgical resection for cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
This update reports observed changes in liver function after stereotactic body radiation therapy in patients with hepatocellular carcinoma o…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures. [NA]
A Mayo Clinic study evaluated the patency of a prototype large plastic biliary stent for palliation of malignant distal biliary strictures; …
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) [Phase 2]
Phase 2 PiCCA trial of panitumumab with cisplatin/gemcitabine for cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial updates on trametinib or combination chemotherapy for refractory or unresectable biliary tract and gallbladder cancers; comple…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma [Phase 2, Phase 3]
This clinical trial update reports a Phase 2/Phase 3 study evaluating radiofrequency ablation combined with cytokine-induced killer cells fo…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Combined HCC-MFCCC
This clinical trial update indicates the Combined HCC-MFCCC study sponsored by the University of Milan has completed its trial. The conditio…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer [NA]
The Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) trial for unresectable cholangiocarcinoma and pancreatic cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD [NA]
This completed clinical trial assessed the risk of bacteremia during directed cholangioscopic examination of the common bile duct in patient…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Endoscopic Therapy of Malignant Bile Duct Strictures [NA]
The trial examining endoscopic therapy for malignant bile duct strictures was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III) [NA]
A completed clinical trial (MIRA III) comparing drug-eluting stents versus covered metal stents for malignant biliary obstruction.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: A Trial Comparing the Uncovered to the Covered Wallstent in the Palliation of Malignant Bile Duct Strictures [NA]
A clinical trial comparing uncovered versus covered Wallstents for palliation of malignant bile duct strictures due to inoperable bile duct …
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts [Phase 2]
Phase 2 study evaluating gemcitabine, capecitabine, and bevacizumab in cholangiocarcinoma (gallbladder and bile duct cancers); the trial has…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers [Phase 2]
Phase 2 trial of cediranib maleate in combination chemotherapy for advanced biliary cancers was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations [Phase 2]
This Phase 2 trial update evaluates chemotherapy combined with either panitumumab or bevacizumab for inoperable cholangiocarcinoma lacking K…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma [Phase 2]
Phase 2 study of cabozantinib as monotherapy in advanced cholangiocarcinoma completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma [Phase 2]
A Phase 2 trial evaluating sunitinib in patients with unresectable or advanced cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Perception Prognosis, Goals of Treatment, and Communication
A completed clinical trial update from Massachusetts General Hospital examining prognosis, goals of treatment, and communication in gastric …